Top Story

AHA and ADA: CV risk assessment, monitoring essential for patients with type 1 diabetes

August 21, 2014

A greater understanding of the pathophysiology, risk prediction and treatment of CVD in patients with type 1 diabetes is essential to minimize the impact of these interrelated conditions, according to a new scientific statement from the American Heart Association and American Diabetes Association.

“CVD is a long-term complication of type 1 diabetes that is a major concern for patients and health care providers. … Despite the known higher risk of CVD in individuals with type 1 diabetes mellitus, the pathophysiology underlying the relationship between CV events, CVD risk factors and type 1 diabetes is not well understood,” the authors wrote in Diabetes Care.

figure FDA News

FDA opens dialogue on interim results of CV safety in diabetes drug trials

August 12, 2014
The FDA has launched a dialogue on how to handle confidentiality of the interim results for cardiovascular outcomes in diabetes treatment trials while new trials are…
In the Journals

Knowing modifiable risk factors may reduce CV death in type 2 diabetes

July 9, 2014
Determining vascular calcification and modifiable risk factors for heart disease could provide patients with type 2 diabetes the insight needed to take steps toward…
Meeting News Coverage

Higher obesity increases odds for cardiovascular, cancer, diabetes deaths

July 8, 2014
Adults with class III obesity are more likely to die from all causes than those within normal weight range, but particularly from heart disease, cancer and diabetes…
CME

Lipid Forum II Highlights

This activity is supported by an educational grant from Genentech.

12/30/2013
Risk stratification and appropriate therapies for various dyslipidemias remain difficult concepts for practitioners…
More »
CME

Practical Lipidology: 2013

This activity is supported by an educational grant from Genentech.

12/1/2013
The rise in the prevalence of obesity in the last few decades and its growing impact on health has driven the…
More »

Filter By:

FDA News

FDA: No clear link between olmesartan, CV risk among patients with diabetes

June 24, 2014
The FDA today announced that a safety review of olmesartan indicates no increased risk for CV events among patients with diabetes.According to a…
Meeting News Coverage Perspective

Empagliflozin reduced BP for patients with type 2 diabetes, hypertension

June 23, 2014
CHICAGO — In patients with type 2 diabetes and hypertension, empagliflozin significantly reduced BP in addition to improving blood glucose…
Meeting News Coverage

More than 10% of patients with acute MI may have undiagnosed diabetes

June 16, 2014
It is estimated that about 10% of patients with MI may also have undiagnosed diabetes, according to new research presented at the American Heart…
Meeting News Coverage

OGTT after MI reveals high undiagnosed diabetes, subsequent high mortality

June 14, 2014
SAN FRANCISCO — New research looking at oral glucose tolerance testing 4 days after both ST-elevation myocardial infarction and non-ST-elevated…
Meeting News Coverage Perspective

Experts debate ACC/AHA lipid guidelines

June 13, 2014
SAN FRANCISCO — Two researchers argued whether or not the recently issued American College of Cardiology and American Heart Association…

Groups launch clinical registry to track, improve quality of diabetes and cardiometabolic care

June 11, 2014
The American College of Cardiology, in collaboration with the American Diabetes Association, American College of Physicians and Joslin Diabetes…
In the Journals

Diabetes yielded negative clinical, economic outcomes after CABG

June 9, 2014
Patients in China with diabetes who were undergoing CABG incurred higher costs and had poorer long-term results than patients without diabetes…
Meeting News Coverage

Weight loss at any age can result in long-term CV benefit

May 22, 2014
A decrease in BMI category at any age in adulthood was associated with improvement in CV risk factors, even if the weight loss was not sustained…
Meeting News Coverage Video

Video: Shared factors of cardiovascular risk and metabolic health in women

May 22, 2014
Endocrine Today caught up with Yehuda Handelsman, MD, FACP, FACE, FNLA, president-elect of the American College of Endocrinology, at AACE’s…
In the Journals

HF severity correlated with diabetes risk

May 21, 2014
Increasing severity of HF was associated with greater risk for the development of diabetes in a new study.However, researchers found that use of…
More Headlines »